Skip to main content

and
  1. Article

    Open Access

    Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma

    Mesenchymal stem/stromal cells (MSCs) have been acknowledged as the most important stromal cells in the bone marrow (BM) microenvironment for physiologic hematopoiesis and the concomitant hematologic malignanc...

    Yu Lu, Chaohui Zheng, Wenxia Zhang, Xuan Liu, Ziwei Zhou in Cancer Cell International (2024)

  2. Article

    Open Access

    Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial

    Aponermin, a circularly permuted tumor necrosis factor-related apoptosis-inducing ligand, is a potential death receptor 4/5-targeted antitumour candidate. Previous phase 1/2 studies have demonstrated the effic...

    Zhongjun **a, Yun Leng, Baijun Fang, Yang Liang, Wei Li, Chengcheng Fu in BMC Cancer (2023)

  3. Article

    Open Access

    CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report

    Adults with relapsed acute lymphoblastic leukemia (ALL) have a poor prognosis, especially in patients who relapsed within 6 months of complete remission 1 (CR1). Allogeneic hematopoietic stem cell transplantat...

    Shupeng Wen, Zhiyun Niu, Lina **ng, Ying Wang, Hang Li, Na Kuang, Jianmin Luo in BMC Cancer (2018)